The U.S. Food and Drug Administration (FDA) today announced an extension to May 3, 2007, of the comment period of the notice of availability that appeared in the Federal Register of January 3, 2007, (72 FR 136). In the notice, FDA requested comments on the draft risk assessment; the proposed risk management plan; and the draft guidance for industry on animal cloning. The agency is taking this action in response to a request for an extension to allow interested persons additional time to submit comments.
To submit electronic comments on the three documents, visit http://www.fda.gov/dockets/ecomments.
The Federal Register Notice is located at: www.fda.gov/OHRMS/DOCKETS/98fr/2003n-0573-nec0001.pdf.
Written comments may be sent to: Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD, 20852. Comments must be received May 3, 2007, and should include the docket number 2003N-0573.
For more information, visit www.fda.gov/cvm/CloneRiskAssessment.htm.